December 6, 2018 Rare Disease Report Potential Paroxysmal Nocturnal Hemoglobinuria Treatment, APL-2, Shows Positive … December 4, 2018 Insider Louisville Apellis shares spike on promising new drug data November 21, 2018 Endpoints Gurnet Point-backed Auregen taps Amgen vet to lead; Ex-Roche RNA chief takes CE… November 21, 2018 BioCentury MANAGEMENT TRACKS: BERGENBIO, ALZAMEND November 21, 2018 BioWorld Appointments and advancements November 20, 2018 Louisville Business First Apellis hires veteran biotech exec for new C-suite role November 20, 2018 Seeking Alpha Apellis Pharmaceuticals appoints Adam Townsend as Chief Commercial Officer October 30, 2018 Retina News APELLIS BEGINS PHASE 3 TRIALS FOR COMPLEMENT INHIBITION IN GA September 16, 2018 Healio OSN’s top news of the week September 13, 2018 BioWorld Clinical data for Sept. 12, 2018
December 6, 2018 Rare Disease Report Potential Paroxysmal Nocturnal Hemoglobinuria Treatment, APL-2, Shows Positive …
November 21, 2018 Endpoints Gurnet Point-backed Auregen taps Amgen vet to lead; Ex-Roche RNA chief takes CE…
November 20, 2018 Seeking Alpha Apellis Pharmaceuticals appoints Adam Townsend as Chief Commercial Officer